Multiple sclerosis
BTK inhibitors and next-gen remyelination approaches after anti-CD20 dominance.
Lenses
EarlierApproval →
SNYFiledcash ok
2026-09-28 (46d)Confirmed
Tolebrutinib · NCT04458051 · PDUFA — tolebrutinib
RHHBYPh3cash ok
2026-12-05 (114d)Company-guided
Fenebrutinib · NCT04586023 · Phase 3 MS readout
NVSPh3cash ok
2027-02-20 (191d)Estimated
Remibrutinib · NCT05147220 · Phase 3 update
PRTAPh2cash ok
2027-05-01 (261d)Estimated
Prasinezumab (neuro) · NCT03100149 · Partner update